CCSC Presentation at the 70th NHF Bleeding Disorders Conference

CCSC Presents: Future of 340B and Sustainability of the HTC 
Saturday, October 13, 2018 
1:00 pm-3:15 pm 
Orlando World Center Marriott 
Orlando, FL 
Room: Grand Ballroom 8A

Click here to download this presentation.

***Sign up to become a member and receive updates, access to useful resources, and practice tools.*** 

Program Overview

Amidst controversy surrounding attempts to repeal and replace the Affordable Care Act (ACA), increasing financial pressures appear to be a mainstay in the US health care system. Rising specialty drug spend-coupled with more stringent payer management efforts in terms of contracting, utilization management, patient cost share coupled with uncertainty surrounding the 340B program and flat federal funding have created a challenging environment for HTCs. CCSC provides a unique forum for HTC clinicians to collaborate with payers in order to facilitate the sustainability of the HTC care model.

Who Should Attend

• Hemophilia Treatment Center Providers and Administrators
• Managed Care and Other Payer Professionals involved in the management of patients with hemophilia

Agenda

Expert Panel

	Johanna Gray  Senior Vice President CRD Associates		Kollet Koulianos, MBA Senior Director Payer Relations National Hemophilia Foundation
	Edmund Pezalla, MD, MPH CEO Enlightenment Bioconsult, LLC		Marisela Trujillo, MSW Administrative Director University of Texas Health Gulf States Hemophilia and Thrombophilia Center